ASTH — Astrana Health Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual income statement for Astrana Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	R2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	561	687	774	1,144	1,387
Cost of Revenue
Gross Profit	92.8	148	178	199	215
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	528	607	686	1,061	1,307
Operating Profit	32.4	80.5	87.4	83	80
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	25.8	178	77.7	86.6	89.8
Provision for Income Taxes
Net Income After Taxes	17.7	122	46.1	45.7	57.8
Minority Interest
Net Income Before Extraordinary Items
Net Income	14.1	37.9	68.9	45.2	60.7
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	14.1	37.9	68.9	45.2	60.7
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.425	1.01	1.66	1.24	1.36